CLOVER HEALTH INVESTMENTS, CORP. /DE financial data

Symbol
CLOV on Nasdaq
Location
Jersey City, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 163% % 1.6%
Return On Equity -26% % -95%
Return On Assets -15% % -127%
Operating Margin -4.4% % -33%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $1,131,971,907 USD 85%
Weighted Average Number of Shares Outstanding, Basic 511,967,146 shares 4.5%
Weighted Average Number of Shares Outstanding, Diluted 511,967,146 shares 4.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,924,308,000 USD 40%
General and Administrative Expense $214,270,000 USD 21%
Operating Income (Loss) $85,529,000 USD -87%
Net Income (Loss) Attributable to Parent $85,549,000 USD -99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $78,301,000 USD -60%
Other Assets, Current $10,649,000 USD -32%
Assets, Current $307,855,000 USD -10%
Property, Plant and Equipment, Net $6,385,000 USD 20%
Operating Lease, Right-of-Use Asset $2,585,000 USD -29%
Other Assets, Noncurrent $24,118,000 USD 82%
Assets $541,011,000 USD -6.8%
Contract with Customer, Liability, Current $17,000 USD -100%
Liabilities, Current $208,823,000 USD -2.2%
Operating Lease, Liability, Noncurrent $2,321,000 USD -29%
Other Liabilities, Noncurrent $23,484,000 USD -10%
Liabilities $232,307,000 USD -3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $528,000 USD
Retained Earnings (Accumulated Deficit) $2,288,352,000 USD -3.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $308,704,000 USD -9.5%
Liabilities and Equity $541,011,000 USD -6.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $16,293,000 USD -163%
Net Cash Provided by (Used in) Financing Activities $31,741,000 USD -845%
Net Cash Provided by (Used in) Investing Activities $8,930,000 USD -2.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $39,104,000 USD -223%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78,301,000 USD -60%
Deferred Tax Assets, Valuation Allowance $407,997,000 USD 1.8%
Deferred Tax Assets, Gross $411,072,000 USD 2%
Operating Lease, Liability $3,296,000 USD -0.93%
Payments to Acquire Property, Plant, and Equipment $185,000 USD -58%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $83,437,000 USD -98%
Lessee, Operating Lease, Liability, to be Paid $3,744,000 USD -4.2%
Property, Plant and Equipment, Gross $13,985,000 USD 25%
Operating Lease, Liability, Current $1,345,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,602,000 USD 39%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,575,000 USD 25%
Operating Lease, Weighted Average Discount Rate, Percent 0.1087 pure 2.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $448,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $425,000 USD -64%
Deferred Tax Assets, Operating Loss Carryforwards $331,313,000 USD 3.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $106,000 USD -65%
Additional Paid in Capital $2,682,663,000 USD 4.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $3,075,000 USD 35%
Share-based Payment Arrangement, Expense $103,657,000 USD -9.3%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%